ep2-selective antagonists pf-04418948 Search Results


92
Selleck Chemicals pf 04418948
Pf 04418948, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ep2-selective+antagonists+pf-04418948/PF-04418948/bio_rxiv__64898__2026__02__08__704632-188-11-13
Average 92 stars, based on 1 article reviews
pf 04418948 - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

86
Pfizer Inc pf 04418948
Pf 04418948, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ep2-selective+antagonists+pf-04418948/04418948+pf/pmc13036645-29-12-5
Average 86 stars, based on 1 article reviews
pf 04418948 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

90
ApexBio ono-ae3208
Ono Ae3208, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ep2-selective+antagonists+pf-04418948/ono+ae3208/10__1096_slash_fj__201802642r-51-102-106
Average 90 stars, based on 1 article reviews
ono-ae3208 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

99
Cayman Chemical selective prostaglandin e2 receptor 2 ep2 antagonist
Fig. 8. Effects of 27-OHC on prostaglandin (PG) synthesis and effects of cyclooxygenase (COX) inhibitors on 27-OHC-enhanced cellular senes- cence. HFL-1 cells were exposed to various concentrations of 27-OHC for 2 wk. COX-1 and COX-2 expression was evaluated by Western blotting (A and B). <t>PGE2</t> and PGD2 release was quantified by enzyme-linked immunoassay (ELISA) (C and D). Cells were treated with 27-OHC in the presence or absence of indo- methacin, a nonselective COX inhibitor; cele- coxib, a selective COX-2 inhibitor; and PF- 04418948, a selective prostaglandin E2 receptor 2 <t>(EP2)</t> antagonist. Cells were harvested and assayed for 3-NT formation (E) and SA--gal activity (F and G). Relative intensity was calcu- lated by dividing each protein band intensity by the -actin band intensity. Values are means SE (n 4). *P 0.05 and **P 0.01 vs. control group. †P 0.05 and ††P 0.01 vs. 27-OHC-treated group.
Selective Prostaglandin E2 Receptor 2 Ep2 Antagonist, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ep2-selective+antagonists+pf-04418948/Prostaglandin+E2/pm27036870-34-155-168
Average 99 stars, based on 1 article reviews
selective prostaglandin e2 receptor 2 ep2 antagonist - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

90
SEKISUI MEDICAL diaminofluorescein-2
Fig. 8. Effects of 27-OHC on prostaglandin (PG) synthesis and effects of cyclooxygenase (COX) inhibitors on 27-OHC-enhanced cellular senes- cence. HFL-1 cells were exposed to various concentrations of 27-OHC for 2 wk. COX-1 and COX-2 expression was evaluated by Western blotting (A and B). <t>PGE2</t> and PGD2 release was quantified by enzyme-linked immunoassay (ELISA) (C and D). Cells were treated with 27-OHC in the presence or absence of indo- methacin, a nonselective COX inhibitor; cele- coxib, a selective COX-2 inhibitor; and PF- 04418948, a selective prostaglandin E2 receptor 2 <t>(EP2)</t> antagonist. Cells were harvested and assayed for 3-NT formation (E) and SA--gal activity (F and G). Relative intensity was calcu- lated by dividing each protein band intensity by the -actin band intensity. Values are means SE (n 4). *P 0.05 and **P 0.01 vs. control group. †P 0.05 and ††P 0.01 vs. 27-OHC-treated group.
Diaminofluorescein 2, supplied by SEKISUI MEDICAL, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ep2-selective+antagonists+pf-04418948/daf+2+da/pm27036870-34-143-149
Average 90 stars, based on 1 article reviews
diaminofluorescein-2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology mouse monoclonal anti cox 2 antibody
Fig. 8. Effects of 27-OHC on prostaglandin (PG) synthesis and effects of cyclooxygenase (COX) inhibitors on 27-OHC-enhanced cellular senes- cence. HFL-1 cells were exposed to various concentrations of 27-OHC for 2 wk. COX-1 and COX-2 expression was evaluated by Western blotting (A and B). <t>PGE2</t> and PGD2 release was quantified by enzyme-linked immunoassay (ELISA) (C and D). Cells were treated with 27-OHC in the presence or absence of indo- methacin, a nonselective COX inhibitor; cele- coxib, a selective COX-2 inhibitor; and PF- 04418948, a selective prostaglandin E2 receptor 2 <t>(EP2)</t> antagonist. Cells were harvested and assayed for 3-NT formation (E) and SA--gal activity (F and G). Relative intensity was calcu- lated by dividing each protein band intensity by the -actin band intensity. Values are means SE (n 4). *P 0.05 and **P 0.01 vs. control group. †P 0.05 and ††P 0.01 vs. 27-OHC-treated group.
Mouse Monoclonal Anti Cox 2 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ep2-selective+antagonists+pf-04418948/Cox-2+Antibody/pm27036870-34-20-37
Average 96 stars, based on 1 article reviews
mouse monoclonal anti cox 2 antibody - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology mouse monoclonal anti actin antibody
Fig. 8. Effects of 27-OHC on prostaglandin (PG) synthesis and effects of cyclooxygenase (COX) inhibitors on 27-OHC-enhanced cellular senes- cence. HFL-1 cells were exposed to various concentrations of 27-OHC for 2 wk. COX-1 and COX-2 expression was evaluated by Western blotting (A and B). <t>PGE2</t> and PGD2 release was quantified by enzyme-linked immunoassay (ELISA) (C and D). Cells were treated with 27-OHC in the presence or absence of indo- methacin, a nonselective COX inhibitor; cele- coxib, a selective COX-2 inhibitor; and PF- 04418948, a selective prostaglandin E2 receptor 2 <t>(EP2)</t> antagonist. Cells were harvested and assayed for 3-NT formation (E) and SA--gal activity (F and G). Relative intensity was calcu- lated by dividing each protein band intensity by the -actin band intensity. Values are means SE (n 4). *P 0.05 and **P 0.01 vs. control group. †P 0.05 and ††P 0.01 vs. 27-OHC-treated group.
Mouse Monoclonal Anti Actin Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ep2-selective+antagonists+pf-04418948/Actin+Antibody/pm27036870-34-24-37
Average 96 stars, based on 1 article reviews
mouse monoclonal anti actin antibody - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology mouse monoclonal anti cyclooygenase 1 cox 1 antibody
Fig. 8. Effects of 27-OHC on prostaglandin (PG) synthesis and effects of cyclooxygenase (COX) inhibitors on 27-OHC-enhanced cellular senes- cence. HFL-1 cells were exposed to various concentrations of 27-OHC for 2 wk. COX-1 and COX-2 expression was evaluated by Western blotting (A and B). <t>PGE2</t> and PGD2 release was quantified by enzyme-linked immunoassay (ELISA) (C and D). Cells were treated with 27-OHC in the presence or absence of indo- methacin, a nonselective COX inhibitor; cele- coxib, a selective COX-2 inhibitor; and PF- 04418948, a selective prostaglandin E2 receptor 2 <t>(EP2)</t> antagonist. Cells were harvested and assayed for 3-NT formation (E) and SA--gal activity (F and G). Relative intensity was calcu- lated by dividing each protein band intensity by the -actin band intensity. Values are means SE (n 4). *P 0.05 and **P 0.01 vs. control group. †P 0.05 and ††P 0.01 vs. 27-OHC-treated group.
Mouse Monoclonal Anti Cyclooygenase 1 Cox 1 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ep2-selective+antagonists+pf-04418948/Cox-1+Antibody/pm27036870-34-15-37
Average 95 stars, based on 1 article reviews
mouse monoclonal anti cyclooygenase 1 cox 1 antibody - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology mouse monoclonal anti lamin a c antibody
Fig. 8. Effects of 27-OHC on prostaglandin (PG) synthesis and effects of cyclooxygenase (COX) inhibitors on 27-OHC-enhanced cellular senes- cence. HFL-1 cells were exposed to various concentrations of 27-OHC for 2 wk. COX-1 and COX-2 expression was evaluated by Western blotting (A and B). <t>PGE2</t> and PGD2 release was quantified by enzyme-linked immunoassay (ELISA) (C and D). Cells were treated with 27-OHC in the presence or absence of indo- methacin, a nonselective COX inhibitor; cele- coxib, a selective COX-2 inhibitor; and PF- 04418948, a selective prostaglandin E2 receptor 2 <t>(EP2)</t> antagonist. Cells were harvested and assayed for 3-NT formation (E) and SA--gal activity (F and G). Relative intensity was calcu- lated by dividing each protein band intensity by the -actin band intensity. Values are means SE (n 4). *P 0.05 and **P 0.01 vs. control group. †P 0.05 and ††P 0.01 vs. 27-OHC-treated group.
Mouse Monoclonal Anti Lamin A C Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ep2-selective+antagonists+pf-04418948/Lamin+A%2FC+Antibody/pm27036870-34-30-37
Average 96 stars, based on 1 article reviews
mouse monoclonal anti lamin a c antibody - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology mouse monoclonal anti p16 antibody
Fig. 8. Effects of 27-OHC on prostaglandin (PG) synthesis and effects of cyclooxygenase (COX) inhibitors on 27-OHC-enhanced cellular senes- cence. HFL-1 cells were exposed to various concentrations of 27-OHC for 2 wk. COX-1 and COX-2 expression was evaluated by Western blotting (A and B). <t>PGE2</t> and PGD2 release was quantified by enzyme-linked immunoassay (ELISA) (C and D). Cells were treated with 27-OHC in the presence or absence of indo- methacin, a nonselective COX inhibitor; cele- coxib, a selective COX-2 inhibitor; and PF- 04418948, a selective prostaglandin E2 receptor 2 <t>(EP2)</t> antagonist. Cells were harvested and assayed for 3-NT formation (E) and SA--gal activity (F and G). Relative intensity was calcu- lated by dividing each protein band intensity by the -actin band intensity. Values are means SE (n 4). *P 0.05 and **P 0.01 vs. control group. †P 0.05 and ††P 0.01 vs. 27-OHC-treated group.
Mouse Monoclonal Anti P16 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ep2-selective+antagonists+pf-04418948/p16+Antibody/pm27036870-34-11-37
Average 96 stars, based on 1 article reviews
mouse monoclonal anti p16 antibody - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc rabbit polyclonal anti p p53 antibody
Fig. 1. Detection of <t>p53</t> in lung fibroblasts. Lung tissues were obtained from healthy controls who had never smoked, healthy exsmokers, and exsmokers with chronic obstructive pulmonary disease (COPD). Local- ization of p53, a senescence-associated protein, was investigated in the lung tissues by immunostaining. Representative photographs of p53 immunoreactivity are shown (A). The boxed area indicates a region of higher magnification. Arrows indicate p53-immunopo- sitive lung fibroblasts. Red, p53; green, vimentin (marker of fibroblasts). The p53 and vimentin double- immunopositive cells were semiquantified using Image J (B). Four strains of primary lung fibroblasts were obtained from the patients. Cells were treated with 27-hydroxycholesterol (27-OHC), and the nuclear frac- tion was obtained. Translocation of phosphorylated p53 (p-p53) into the nucleus was evaluated by Western blotting (C). Relative intensity was calculated by divid- ing the p-p53 band intensity by the lamin A/C band intensity. Values are means SE. **P 0.01 vs. healthy control who had never smoked (HNS). ††P 0.01 vs. healthy exsmoker (HES).
Rabbit Polyclonal Anti P P53 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ep2-selective+antagonists+pf-04418948/p53+Antibody/pm27036870-34-53-59
Average 97 stars, based on 1 article reviews
rabbit polyclonal anti p p53 antibody - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology mouse monoclonal anti p53 antibody
Fig. 1. Detection of <t>p53</t> in lung fibroblasts. Lung tissues were obtained from healthy controls who had never smoked, healthy exsmokers, and exsmokers with chronic obstructive pulmonary disease (COPD). Local- ization of p53, a senescence-associated protein, was investigated in the lung tissues by immunostaining. Representative photographs of p53 immunoreactivity are shown (A). The boxed area indicates a region of higher magnification. Arrows indicate p53-immunopo- sitive lung fibroblasts. Red, p53; green, vimentin (marker of fibroblasts). The p53 and vimentin double- immunopositive cells were semiquantified using Image J (B). Four strains of primary lung fibroblasts were obtained from the patients. Cells were treated with 27-hydroxycholesterol (27-OHC), and the nuclear frac- tion was obtained. Translocation of phosphorylated p53 (p-p53) into the nucleus was evaluated by Western blotting (C). Relative intensity was calculated by divid- ing the p-p53 band intensity by the lamin A/C band intensity. Values are means SE. **P 0.01 vs. healthy control who had never smoked (HNS). ††P 0.01 vs. healthy exsmoker (HES).
Mouse Monoclonal Anti P53 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ep2-selective+antagonists+pf-04418948/p53+Antibody/pm27036870-34-7-37
Average 96 stars, based on 1 article reviews
mouse monoclonal anti p53 antibody - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


Fig. 8. Effects of 27-OHC on prostaglandin (PG) synthesis and effects of cyclooxygenase (COX) inhibitors on 27-OHC-enhanced cellular senes- cence. HFL-1 cells were exposed to various concentrations of 27-OHC for 2 wk. COX-1 and COX-2 expression was evaluated by Western blotting (A and B). PGE2 and PGD2 release was quantified by enzyme-linked immunoassay (ELISA) (C and D). Cells were treated with 27-OHC in the presence or absence of indo- methacin, a nonselective COX inhibitor; cele- coxib, a selective COX-2 inhibitor; and PF- 04418948, a selective prostaglandin E2 receptor 2 (EP2) antagonist. Cells were harvested and assayed for 3-NT formation (E) and SA--gal activity (F and G). Relative intensity was calcu- lated by dividing each protein band intensity by the -actin band intensity. Values are means SE (n 4). *P 0.05 and **P 0.01 vs. control group. †P 0.05 and ††P 0.01 vs. 27-OHC-treated group.

Journal: American journal of physiology. Lung cellular and molecular physiology

Article Title: 27-Hydroxycholesterol accelerates cellular senescence in human lung resident cells.

doi: 10.1152/ajplung.00351.2015

Figure Lengend Snippet: Fig. 8. Effects of 27-OHC on prostaglandin (PG) synthesis and effects of cyclooxygenase (COX) inhibitors on 27-OHC-enhanced cellular senes- cence. HFL-1 cells were exposed to various concentrations of 27-OHC for 2 wk. COX-1 and COX-2 expression was evaluated by Western blotting (A and B). PGE2 and PGD2 release was quantified by enzyme-linked immunoassay (ELISA) (C and D). Cells were treated with 27-OHC in the presence or absence of indo- methacin, a nonselective COX inhibitor; cele- coxib, a selective COX-2 inhibitor; and PF- 04418948, a selective prostaglandin E2 receptor 2 (EP2) antagonist. Cells were harvested and assayed for 3-NT formation (E) and SA--gal activity (F and G). Relative intensity was calcu- lated by dividing each protein band intensity by the -actin band intensity. Values are means SE (n 4). *P 0.05 and **P 0.01 vs. control group. †P 0.05 and ††P 0.01 vs. 27-OHC-treated group.

Article Snippet: Commercially available reagents were obtained as follows: mouse monoclonal anti-p53 antibody, mouse monoclonal anti-p16 antibody, mouse monoclonal anti-cyclooygenase-1 (COX-1) antibody, mouse monoclonal anti-COX-2 antibody, mouse monoclonal anti- -actin antibody, and mouse monoclonal anti-lamin A/C antibody were from Santa Cruz Biotechnology (Dallas, TX); rabbit polyclonal anti-p21 antibody, rabbit polyclonal anti-phosphorylated (p)-retinoblastoma (pRB) antibody and rabbit polyclonal anti-p-p53 antibody were from Cell Signaling Technology (Beverly, MA); rabbit polyclonal antisterol 27-hydroxylase antibody and 27-OHC were from Avanti Polar Lipids (Alabaster, AL); mouse anti-CD68 antibody was from BioLegend (San Diego, CA); fibronectin enzyme-linked immunosorbent assay (ELISA) kit, goat fluorescein isothiocyanate polyclonal secondary antibody, and rabbit Dylight 650 polyclonal secondary antibody were from Abcam (Cambridge, UK); indomethacin, a nonselective COX inhibitor, and celecoxib, a selective 27-OHC-2 inhibitor, were from Sigma (St. Louis, MO); manganese (III) tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP), a peroxynitrite scavenger, was from Calbiochem (La Jolla, CA); diaminofluorescein-2, a fluorescent indicator, was from Sekisui Medical (Tokyo, Japan); PF-04418948, a selective prostaglandin E2 receptor 2 (EP2) antagonist and EIA prostaglandin kit were from Cayman Chemical (San Diego, CA); Dulbecco’s Modified Eagle’s Medium (DMEM), fetal calf serum (FCS), and antibiotic-antimycotic were purchased from Invitrogen Life Technologies (Grand Island, NY).

Techniques: Expressing, Western Blot, Enzyme-linked Immunosorbent Assay, Activity Assay, Control

Fig. 1. Detection of p53 in lung fibroblasts. Lung tissues were obtained from healthy controls who had never smoked, healthy exsmokers, and exsmokers with chronic obstructive pulmonary disease (COPD). Local- ization of p53, a senescence-associated protein, was investigated in the lung tissues by immunostaining. Representative photographs of p53 immunoreactivity are shown (A). The boxed area indicates a region of higher magnification. Arrows indicate p53-immunopo- sitive lung fibroblasts. Red, p53; green, vimentin (marker of fibroblasts). The p53 and vimentin double- immunopositive cells were semiquantified using Image J (B). Four strains of primary lung fibroblasts were obtained from the patients. Cells were treated with 27-hydroxycholesterol (27-OHC), and the nuclear frac- tion was obtained. Translocation of phosphorylated p53 (p-p53) into the nucleus was evaluated by Western blotting (C). Relative intensity was calculated by divid- ing the p-p53 band intensity by the lamin A/C band intensity. Values are means SE. **P 0.01 vs. healthy control who had never smoked (HNS). ††P 0.01 vs. healthy exsmoker (HES).

Journal: American journal of physiology. Lung cellular and molecular physiology

Article Title: 27-Hydroxycholesterol accelerates cellular senescence in human lung resident cells.

doi: 10.1152/ajplung.00351.2015

Figure Lengend Snippet: Fig. 1. Detection of p53 in lung fibroblasts. Lung tissues were obtained from healthy controls who had never smoked, healthy exsmokers, and exsmokers with chronic obstructive pulmonary disease (COPD). Local- ization of p53, a senescence-associated protein, was investigated in the lung tissues by immunostaining. Representative photographs of p53 immunoreactivity are shown (A). The boxed area indicates a region of higher magnification. Arrows indicate p53-immunopo- sitive lung fibroblasts. Red, p53; green, vimentin (marker of fibroblasts). The p53 and vimentin double- immunopositive cells were semiquantified using Image J (B). Four strains of primary lung fibroblasts were obtained from the patients. Cells were treated with 27-hydroxycholesterol (27-OHC), and the nuclear frac- tion was obtained. Translocation of phosphorylated p53 (p-p53) into the nucleus was evaluated by Western blotting (C). Relative intensity was calculated by divid- ing the p-p53 band intensity by the lamin A/C band intensity. Values are means SE. **P 0.01 vs. healthy control who had never smoked (HNS). ††P 0.01 vs. healthy exsmoker (HES).

Article Snippet: Commercially available reagents were obtained as follows: mouse monoclonal anti-p53 antibody, mouse monoclonal anti-p16 antibody, mouse monoclonal anti-cyclooygenase-1 (COX-1) antibody, mouse monoclonal anti-COX-2 antibody, mouse monoclonal anti- -actin antibody, and mouse monoclonal anti-lamin A/C antibody were from Santa Cruz Biotechnology (Dallas, TX); rabbit polyclonal anti-p21 antibody, rabbit polyclonal anti-phosphorylated (p)-retinoblastoma (pRB) antibody and rabbit polyclonal anti-p-p53 antibody were from Cell Signaling Technology (Beverly, MA); rabbit polyclonal antisterol 27-hydroxylase antibody and 27-OHC were from Avanti Polar Lipids (Alabaster, AL); mouse anti-CD68 antibody was from BioLegend (San Diego, CA); fibronectin enzyme-linked immunosorbent assay (ELISA) kit, goat fluorescein isothiocyanate polyclonal secondary antibody, and rabbit Dylight 650 polyclonal secondary antibody were from Abcam (Cambridge, UK); indomethacin, a nonselective COX inhibitor, and celecoxib, a selective 27-OHC-2 inhibitor, were from Sigma (St. Louis, MO); manganese (III) tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP), a peroxynitrite scavenger, was from Calbiochem (La Jolla, CA); diaminofluorescein-2, a fluorescent indicator, was from Sekisui Medical (Tokyo, Japan); PF-04418948, a selective prostaglandin E2 receptor 2 (EP2) antagonist and EIA prostaglandin kit were from Cayman Chemical (San Diego, CA); Dulbecco’s Modified Eagle’s Medium (DMEM), fetal calf serum (FCS), and antibiotic-antimycotic were purchased from Invitrogen Life Technologies (Grand Island, NY).

Techniques: Immunostaining, Marker, Translocation Assay, Western Blot, Control

Fig. 5. Effects of 27-OHC on senescence- associated protein production, senescence- associated -galactosidase (SA--gal) activ- ity, and cell growth in human lung fibro- blasts. Human fetal lung fibroblasts (HFL-1) were exposed to various concentrations of 27-OHC for 24 h, and cell lysates were harvested. Expression of senescence-associ- ated protein was evaluated by Western blot- ting. Band intensity for each senescence- associated protein, including p53 (A), p21 (B), p16 (C), and phosphorylated retinoblas- toma (p-pRB) (D), was assessed by densi- tometry and is expressed relative to the -ac- tin band intensity. SA--gal activity (E and F) and cell growth (G) were determined in 20th passage cells after chronic exposure to 27-OHC for 2 wk. Arrows indicate SA-- gal-positive cells. Values are means SE (n 4). *P 0.05 and **P 0.01 vs. control group. ns, Not significant.

Journal: American journal of physiology. Lung cellular and molecular physiology

Article Title: 27-Hydroxycholesterol accelerates cellular senescence in human lung resident cells.

doi: 10.1152/ajplung.00351.2015

Figure Lengend Snippet: Fig. 5. Effects of 27-OHC on senescence- associated protein production, senescence- associated -galactosidase (SA--gal) activ- ity, and cell growth in human lung fibro- blasts. Human fetal lung fibroblasts (HFL-1) were exposed to various concentrations of 27-OHC for 24 h, and cell lysates were harvested. Expression of senescence-associ- ated protein was evaluated by Western blot- ting. Band intensity for each senescence- associated protein, including p53 (A), p21 (B), p16 (C), and phosphorylated retinoblas- toma (p-pRB) (D), was assessed by densi- tometry and is expressed relative to the -ac- tin band intensity. SA--gal activity (E and F) and cell growth (G) were determined in 20th passage cells after chronic exposure to 27-OHC for 2 wk. Arrows indicate SA-- gal-positive cells. Values are means SE (n 4). *P 0.05 and **P 0.01 vs. control group. ns, Not significant.

Article Snippet: Commercially available reagents were obtained as follows: mouse monoclonal anti-p53 antibody, mouse monoclonal anti-p16 antibody, mouse monoclonal anti-cyclooygenase-1 (COX-1) antibody, mouse monoclonal anti-COX-2 antibody, mouse monoclonal anti- -actin antibody, and mouse monoclonal anti-lamin A/C antibody were from Santa Cruz Biotechnology (Dallas, TX); rabbit polyclonal anti-p21 antibody, rabbit polyclonal anti-phosphorylated (p)-retinoblastoma (pRB) antibody and rabbit polyclonal anti-p-p53 antibody were from Cell Signaling Technology (Beverly, MA); rabbit polyclonal antisterol 27-hydroxylase antibody and 27-OHC were from Avanti Polar Lipids (Alabaster, AL); mouse anti-CD68 antibody was from BioLegend (San Diego, CA); fibronectin enzyme-linked immunosorbent assay (ELISA) kit, goat fluorescein isothiocyanate polyclonal secondary antibody, and rabbit Dylight 650 polyclonal secondary antibody were from Abcam (Cambridge, UK); indomethacin, a nonselective COX inhibitor, and celecoxib, a selective 27-OHC-2 inhibitor, were from Sigma (St. Louis, MO); manganese (III) tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP), a peroxynitrite scavenger, was from Calbiochem (La Jolla, CA); diaminofluorescein-2, a fluorescent indicator, was from Sekisui Medical (Tokyo, Japan); PF-04418948, a selective prostaglandin E2 receptor 2 (EP2) antagonist and EIA prostaglandin kit were from Cayman Chemical (San Diego, CA); Dulbecco’s Modified Eagle’s Medium (DMEM), fetal calf serum (FCS), and antibiotic-antimycotic were purchased from Invitrogen Life Technologies (Grand Island, NY).

Techniques: Expressing, Western Blot, Activity Assay, Control

Fig. 6. Effects of 27-OHC on senescence-associated protein production, SA--gal activity, and cell growth in adult bronchial epithelial cells. Adult bronchial epi- thelial cells were obtained from healthy subjects, and the cells were exposed to various concentrations of 27-OHC for 24 h. Expression of senescence-associated proteins was evaluated by Western blotting. Band in- tensity for each senescence-associated protein, includ- ing p53 (A) and p16 (B), was assessed by densitometry and is expressed relative to the -actin band intensity. SA--gal activity (C) and cell growth (D) were deter- mined in 6th passage cells after chronic exposure to 27-OHC for 2 wk. Values are means SE (n 4). *P 0.05 and **P 0.01 vs. control group.

Journal: American journal of physiology. Lung cellular and molecular physiology

Article Title: 27-Hydroxycholesterol accelerates cellular senescence in human lung resident cells.

doi: 10.1152/ajplung.00351.2015

Figure Lengend Snippet: Fig. 6. Effects of 27-OHC on senescence-associated protein production, SA--gal activity, and cell growth in adult bronchial epithelial cells. Adult bronchial epi- thelial cells were obtained from healthy subjects, and the cells were exposed to various concentrations of 27-OHC for 24 h. Expression of senescence-associated proteins was evaluated by Western blotting. Band in- tensity for each senescence-associated protein, includ- ing p53 (A) and p16 (B), was assessed by densitometry and is expressed relative to the -actin band intensity. SA--gal activity (C) and cell growth (D) were deter- mined in 6th passage cells after chronic exposure to 27-OHC for 2 wk. Values are means SE (n 4). *P 0.05 and **P 0.01 vs. control group.

Article Snippet: Commercially available reagents were obtained as follows: mouse monoclonal anti-p53 antibody, mouse monoclonal anti-p16 antibody, mouse monoclonal anti-cyclooygenase-1 (COX-1) antibody, mouse monoclonal anti-COX-2 antibody, mouse monoclonal anti- -actin antibody, and mouse monoclonal anti-lamin A/C antibody were from Santa Cruz Biotechnology (Dallas, TX); rabbit polyclonal anti-p21 antibody, rabbit polyclonal anti-phosphorylated (p)-retinoblastoma (pRB) antibody and rabbit polyclonal anti-p-p53 antibody were from Cell Signaling Technology (Beverly, MA); rabbit polyclonal antisterol 27-hydroxylase antibody and 27-OHC were from Avanti Polar Lipids (Alabaster, AL); mouse anti-CD68 antibody was from BioLegend (San Diego, CA); fibronectin enzyme-linked immunosorbent assay (ELISA) kit, goat fluorescein isothiocyanate polyclonal secondary antibody, and rabbit Dylight 650 polyclonal secondary antibody were from Abcam (Cambridge, UK); indomethacin, a nonselective COX inhibitor, and celecoxib, a selective 27-OHC-2 inhibitor, were from Sigma (St. Louis, MO); manganese (III) tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP), a peroxynitrite scavenger, was from Calbiochem (La Jolla, CA); diaminofluorescein-2, a fluorescent indicator, was from Sekisui Medical (Tokyo, Japan); PF-04418948, a selective prostaglandin E2 receptor 2 (EP2) antagonist and EIA prostaglandin kit were from Cayman Chemical (San Diego, CA); Dulbecco’s Modified Eagle’s Medium (DMEM), fetal calf serum (FCS), and antibiotic-antimycotic were purchased from Invitrogen Life Technologies (Grand Island, NY).

Techniques: Activity Assay, Expressing, Western Blot, Control